reduc confid abil achiev prior
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jul
estim jul
price data jul
rate updat jul
currenc amount express
methodolog valu compani
assign mylan no-moat stabl trend rate
also lower fair valu estim per share
confid compani abil
introduc complex new therapi replenish pipelin
beyond anticip fiscal launch think
weigh margin previous expect
lead global gener manufactur industri
undergo dramat chang also one
controversi publicli
compani rapid gener market declin due
price pressur entri gener competit
largest specialti drug epipen treatment anaphylaxi
 food drug administr warn letter one
facil congression alleg price goug
epipen high debt load share declin
june high approxim mylan share
affect much closest peer teva
like due smaller exposur north america
lower debt load slightli
insul gener launch advair complex
respiratori drug copaxon treatment multipl
sclerosi recent progress develop biosimilar
mylan global scale vertic integr provid
firm low-cost edg highli fragment market
firm control world gener
product teva sandoz subsidiari novarti
account approxim half gener sale
 europ balanc market highli
fragment low-cost manufactur grown rapidli
activ compet less differenti commod
gener drug regulatori hurdl lower
european countri although compani
probabl maintain share current market increas
competit dynam like make challeng
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
regist netherland lead gener drugmak
roughli manufactur facil although compani
form compani posit second-largest gener
compani larg attribut acquisit matrix laboratori
gener busi germany-bas merck kgaa portfolio
gener specialti over-the-count activ
ingredi medicin
manufactur epipen treatment anaphylaxi acquir
merk kgaa transact
predominantli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
